Consistent with past practices, the number of Performance Units was based on the average closing price of CSX common stock for November 2018, December 2018 and January 2019 of $67.01. The number of Stock Options was calculated based on the Black-Scholes value of $17.48, which, consistent with past practices, was determined using the average closing price of CSX common stock for November 2018, December 2018 and January 2019 of $67.01.One-third of the Stock Options will vest on each of February 6, 2020, February 6, 2021, and February 6, 2022, assuming the completion of the applicable vesting period. If unexercised, the Stock Options will expire on February 6, 2029. The exercise price of each Stock Option is based on the closing price of CSX common stock on the date of the grant, which was February 6, 2019.
The foregoing descriptions of the 2019-2021 Plan and the awards made pursuant to the new long-term incentive program are qualified in their entirety by reference to the 2019-2021 Plan and the form of 2019 Stock Option Agreement, which are attached to this Current Report on Form8-K as Exhibits 10.1 and 10.2, and incorporated herein by reference.
On February 6, 2019, the CSX Board of Directors also approved an increase in the annual incentive opportunity for James M. Foote, the Company’s President and Chief Executive Officer, to 140% of his annual base salary, as well as an increase to his target long-term incentive equity award from $9 million to $10 million, effective February 6, 2019.
Item 9.01. Exhibits.
(d) The following exhibit is being filed as part of this report: